- Associated Press - Wednesday, November 17, 2010

An experimental drug dramatically lowered bad cholesterol (LDL) while raising so-called good cholesterol (HDL) to record levels in a study of 1,623 people.

The participants were already taking cholesterol-lowering statin drugs because they were at higher than usual risk of a heart attack.

Results of the study of the drug, Merck & Co.’s anacetrapib:

_LDL: Scores fell from 81 to 45 in the drug group, and from 82 to 77 for those given dummy pills. That’s a 40 percent improvement for those on the drug versus the others.

_HDL: Scores rose from 41 to 101 in the drug group, and from 40 to 46 in those on dummy pills. That’s a 138 percent improvement over the placebo group.

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.


Click to Read More and View Comments

Click to Hide